IRCT20201007048955N1Not yet recruiting未知
Evaluation the efficacy of autologous platelet rich plasma (PRP) in prevention of hypertrophic scar at the site of sternotomy in adults with open heart surgery in Shahid Modarres Hospital in 2020-2021
Clinical Research Development Center0 sites50 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •Not having diabetes
- •Not having autoimmune diseases
- •Not having thrombocytopenia(platelets below 150000)
- •Not receiving glucocorticoids
Exclusion Criteria
- •Patient not referring to the doctor for surveillance
- •Death of the patient during the surveillance period
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Comparison between autologous platelet rich fibrin and autologous platelet rich plasma in myringoplasty.CTRI/2022/09/045567Vinayaka mission medical college
Completed
Not Applicable
Efficacy of Platelet Rich Plasma and fractional co2 laser in treatment of acne scar of faceacne scar.scar cndition and fibrosis of skinIRCT2014080218648N1Isfahan University of Medical Sciences32
Recruiting
Not Applicable
Impact of platelet-rich plasma on anal fissureIRCT20201225049826N1Shahid Beheshti University of Medical Sciences60
Recruiting
Phase 3
Efficacy of Intraoperative autologous platelet rich plasma injection during carpal tunnel release. A double-blind, randomized controlled trialModerate to severe carpal tunnel syndrome patients requiring carpal tunnel release surgerysevere carpal tunnel syndromecarpal tunnel releaseplatelet-rich plasmacarpal tunnel syndromePRPTCTR20220915001Faculty of medicine, Siriraj hospital, Mahidol university35
Recruiting
Not Applicable
Assessment the effect of using autologous platelet rich plasma (PRP) in prevention of hypertrophic scarHypertrophic scarIRCT20201007048955N2Clinical Research Development Center50
